Yaxon Bio Care Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
as on 03-07-2024
- Paid Up Capital ₹ 4.00 M
as on 03-07-2024
- Company Age 13 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.17 Cr
as on 03-07-2024
- Revenue 1.60%
(FY 2023)
- Profit 10.62%
(FY 2023)
- Ebitda 53.92%
(FY 2023)
- Net Worth 57.44%
(FY 2023)
- Total Assets 116.95%
(FY 2023)
About Yaxon Bio Care
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 4.00 M.
The company currently has active open charges totaling ₹4.17 Cr.
Nitin Arneja, Chiranjeev Cheema, Alok Pathak, and One other member serve as directors at the Company.
- CIN/LLPIN
U74140DL2011PTC219437
- Company No.
219437
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 May 2011
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Yaxon Bio Care Private Limited offer?
Yaxon Bio Care Private Limited offers a wide range of products and services, including Ayurvedic,Herbal Products & Medicine, Ayurvedic Medicine, Ayurvedic, Herbal Oils and Cosmetics, Aloe Vera Cosmetics, Common Disease Medicines, Pharmaceutical Syrup, Anti Infective Drugs & Medicines, Antifungal Cream, Ointment & Powder, Hair Growth Medicine, Anti Allergic Drug.
Who are the key members and board of directors at Yaxon Bio Care?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nitin Arneja  | Director | 19-May-2011 | Current |
| Chiranjeev Cheema | Director | 19-May-2011 | Current |
| Alok Pathak | Director | 24-Feb-2022 | Current |
| Vipin Satija | Director | 19-May-2011 | Current |
Financial Performance of Yaxon Bio Care.
Yaxon Bio Care Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 1.6% increase. The company also saw a substantial improvement in profitability, with a 10.62% increase in profit. The company's net worth Soared by an impressive increase of 57.44%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Yaxon Bio Care?
In 2023, Yaxon Bio Care had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 09 Nov 2023 | ₹3.30 M | Open |
Others Creation Date: 16 Sep 2022 | ₹3.84 Cr | Open |
How Many Employees Work at Yaxon Bio Care?
Yaxon Bio Care has a workforce of 48 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Yaxon Bio Care, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Yaxon Bio Care's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
